MedCap AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0009160872
SEK
540.00
-11 (-2.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Flat results in Jun 25

  • ROCE(HY) Lowest at 15.86%
  • INTEREST(Q) Highest at SEK 6.9 MM
2

With ROE of 15.26%, it has a very expensive valuation with a 6.21 Price to Book Value

3

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 8,199 Million (Small Cap)

stock-summary
P/E

41.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.06

stock-summary
Return on Equity

14.65%

stock-summary
Price to Book

5.86

Revenue and Profits:
Net Sales:
522 Million
(Quarterly Results - Jun 2025)
Net Profit:
54 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.04%
0%
-11.04%
6 Months
26.91%
0%
26.91%
1 Year
-2.88%
0%
-2.88%
2 Years
74.19%
0%
74.19%
3 Years
155.92%
0%
155.92%
4 Years
231.7%
0%
231.7%
5 Years
133.77%
0%
133.77%

MedCap AB for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
19.96%
EBIT Growth (5y)
29.85%
EBIT to Interest (avg)
10.65
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.16
Sales to Capital Employed (avg)
1.30
Tax Ratio
20.23%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
19.53%
ROE (avg)
14.67%
Valuation key factors
Factor
Value
P/E Ratio
41
Industry P/E
Price to Book Value
6.21
EV to EBIT
32.36
EV to EBITDA
21.60
EV to Capital Employed
7.31
EV to Sales
4.30
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
22.60%
ROE (Latest)
15.26%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 13.98% vs 18.54% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -5.95% vs 22.01% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "521.70",
          "val2": "457.70",
          "chgp": "13.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "113.00",
          "val2": "93.50",
          "chgp": "20.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.90",
          "val2": "5.80",
          "chgp": "18.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "53.70",
          "val2": "57.10",
          "chgp": "-5.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "151.20%",
          "val2": "144.00%",
          "chgp": "0.72%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 13.82% vs 42.84% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 21.28% vs 46.19% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,806.70",
          "val2": "1,587.40",
          "chgp": "13.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "345.90",
          "val2": "311.10",
          "chgp": "11.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "18.50",
          "val2": "15.60",
          "chgp": "18.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "21.10",
          "val2": "0.80",
          "chgp": "2,537.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "209.20",
          "val2": "172.50",
          "chgp": "21.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "135.30%",
          "val2": "139.60%",
          "chgp": "-0.43%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
521.70
457.70
13.98%
Operating Profit (PBDIT) excl Other Income
113.00
93.50
20.86%
Interest
6.90
5.80
18.97%
Exceptional Items
-4.00
0.00
Consolidate Net Profit
53.70
57.10
-5.95%
Operating Profit Margin (Excl OI)
151.20%
144.00%
0.72%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 13.98% vs 18.54% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -5.95% vs 22.01% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,806.70
1,587.40
13.82%
Operating Profit (PBDIT) excl Other Income
345.90
311.10
11.19%
Interest
18.50
15.60
18.59%
Exceptional Items
21.10
0.80
2,537.50%
Consolidate Net Profit
209.20
172.50
21.28%
Operating Profit Margin (Excl OI)
135.30%
139.60%
-0.43%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 13.82% vs 42.84% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 21.28% vs 46.19% in Dec 2023

stock-summaryCompany CV
About MedCap AB stock-summary
stock-summary
MedCap AB
Pharmaceuticals & Biotechnology
MedCap AB (publ) is a Sweden-based private equity company engaged in investments in and development of companies active primarily within the medical equipment sector. The Company reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.
Company Coordinates stock-summary
Company Details
Sundbybergsvagen 1 , SOLNA None : 171 73
stock-summary
Tel: 46 8 34711046 8 347110
stock-summary
Registrar Details